Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Talampanel Treatment Report
What is Talampanel?

A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of Talampanel in Subjects With Amyotrophic Lateral Sclerosis (ALS) Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Slow my ALS progress 13 5
Other 5 0
drug trail 3 0
drug trial 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 17%
Moderate
0 0%
Mild
3 50%
None
2 33%

Most commonly reported side effects

Dizziness
3 50%
lethargy, don't do housework
1 17%
Depression with increased dosage
1 17%
Fatigue and sleepiness
1 17%
  • Mild
  • Moderate
  • Severe

Stop Reasons

Why Patients Stopped Taking Talampanel (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%
Side effects too severe
1 100% Side effects too severe: 100%

See all 1 patient who’ve stopped taking Talampanel

Duration See details about how long patients take this treatment ▼

Currently Taking Talampanel

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
12
3
0

Stopped Taking Talampanel

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
5 83%
Usually
0 0%
Sometimes
1 17%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 17%
Somewhat
0 0%
A little
0 0%
Not at all
5 83%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
5 83%

Report created on November 23, 2009.